Skip to main content
. 2022 Jan 21;36(2):230–238. doi: 10.1007/s00540-022-03036-9

Table 2.

QOL before and after ARDS treatment

Variable Before ARDS After ARDS
Presence of joba 2239 (49.7) 2294 (51.5)
Annual income levelb
 Q1 (lowest) 1321 (29.7) 1380 (31.0)
 Q2 755 (17.0) 682 (15.3)
 Q3 903 (20.3) 882 (19.8)
 Q4 (highest) 1380 (31.0) 1354 (30.4)
 Unknown 93 (2.1) 154 (3.5)
Disabilityc
 Mild to moderate 454 (10.2) 540 (12.1)
 Severe 568 (12.8) 789 (17.7)
Disability type
 Physical disability 402 (9.0) 435 (9.8)
 Brain lesion disability 210 (4.7) 346 (7.8)
 Visual disturbance 82 (1.8) 92 (2.1)
 Hearing disability 98 (2.2) 114 (2.6)
 Speech disability 3 (0.1) 5 (0.1)
 Intellectual disorder 55 (1.2) 60 (1.3)
 Autism 1 (0.0) 1 (0.0)
 Mental disorder 38 (0.9) 37 (0.8)
 Renal disorder 59 (1.3) 99 (2.2)
 Heart disorder 5 (0.1) 9 (0.2)
 Respiratory disability 51 (1.1) 117 (2.6)
 Hepatopathy 3 (0.1) 4 (0.1)
 Facial disfigurement 0 (0.0) 0 (0.0)
 Intestinal and urinary fistulae 9 (0.2) 12 (0.3)
 Epilepsy 6 (0.1) 6 (0.1)

1298 (29.2%) experienced decreased income, 334 (7.5%) lost job, and 327 (7.3%) had newly acquired disability. 66 (1.5%) have newly acquired respiratory disability

Total QOL worsening occurred in 1667 (37.4%) among ARDS survivors

QOL, quality of life; ARDS, acute respiratory distress syndrome